The WHO has granted prequalification approval—the first ever—for a malaria drug specifically for newborns and infants, clearing the way for wider use. This milestone could dramatically improve treatment access and reduce malaria‑related deaths among the youngest patients, especially in high‑burden African countries.
The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time. The post WHO approves first malaria treatment for infants appeared first on Vanguard News.